The challenge of an expanded therapeutic window in pulmonary hypertension
- PMID: 31949305
- DOI: 10.1038/s41569-020-0332-9
The challenge of an expanded therapeutic window in pulmonary hypertension
References
-
- Galie, N. et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart J. 37, 67–119 (2016). - DOI
-
- Strange, G. et al. Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: the delay study. Pulm. Circ. 3, 89–94 (2013). - DOI
-
- Assad, T. R. et al. Prognostic effect and longitudinal hemodynamic assessment of borderline pulmonary hypertension. JAMA Cardiol. 2, 1361–1368 (2017). - DOI
-
- Simonneau, G. et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir. J. https://doi.org/10.1183/13993003.01913-2018 (2019). - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical